Academic
Publications
Proton Radiotherapy for Liver Tumors: Dosimetric Advantages Over Photon Plans

Proton Radiotherapy for Liver Tumors: Dosimetric Advantages Over Photon Plans,10.1016/j.meddos.2007.04.008,Medical Dosimetry,Xiaochun Wang,Sunil Krish

Proton Radiotherapy for Liver Tumors: Dosimetric Advantages Over Photon Plans   (Citations: 2)
BibTex | RIS | RefWorks Download
The purpose of the study is to dosimetrically investigate the advantages of proton radiotherapy over photon radiotherapy for liver tumors. The proton plan and the photon plan were designed using commercial treatment planning systems. The treatment target dose conformity and heterogeneity and dose-volume analyses of normal structures were compared between proton and photon radiotherapy for 9 patients with liver tumors. Proton radiotherapy delivered a more conformal target dose with slightly less homogeneity when compared with photon radiotherapy. Protons significantly reduced the fractional volume of liver receiving dose greater or equal to 30 Gy (V30) and the mean liver dose. The stomach and duodenal V45 were significantly lower with the use of proton radiotherapy. The V40 and V50 of the heart and the maximum spinal cord dose were also significantly lower with the use of proton radiotherapy. Protons were better able to spare one kidney completely and deliver less dose to one (generally the left) kidney than photons. The mean dose to the total body and most critical structures was significantly decreased using protons when compared to corresponding photon plans. In conclusion, our study suggests the dosimetric benefits of proton radiotherapy over photon radiotherapy. These dosimetric advantages of proton plans may permit further dose escalation with lower risk of complications.
Journal: Medical Dosimetry - MED DOSIM , vol. 33, no. 4, pp. 259-267, 2008
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...Several modalities have been used for the treatment of hepatocellular carcinomas (HCC) and metastatic liver tumours [4-10] including surgery, transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection therapy, microwave coagulation therapy, radiotherapy and liver transplantation...

    Tsair-Fwu Leeet al. Helical tomotherapy for single and multiple liver tumours

Sort by: